Delivery Order SPE2DB22D1106-SPE2DB25FFBV1
Award Date 8/6/25
Potential Completion Date 8/7/25
Potential Value $4.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Dasatinib 100 mg tablets in a 30-count package, with a contract ceiling value of $4,816.96. This non-set-aside, competitively awarded delivery order employs firm fixed pricing and is scheduled for completion by April 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $47,320.66 to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets (30-count units). This competitive award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dasatinib 80 mg tablets (30-count packaging) under a firm fixed-price contract valued at $82,393.53. The order is set to be completed by July 29, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dasatinib 140 mg tablets in a quantity of 30 units, with a contract ceiling value of $3,744.14. This competitively awarded, firm fixed-price delivery order was established on September 8, 2025, with an ultimate completion date of September 9, 2025. The contract represents a child award under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $8,260.56 to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets (30-count units) with a firm fixed price structure. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively made with no set-aside designation, and delivery is...
- The Defense Logistics Agency awarded a delivery order valued at $23,157.77 to AmerisourceBergen Drug Corp for the supply of Dasatinib 80 mg tablets (30-count units) under a firm fixed-price contract type. The order was competitively awarded without set-aside designation and carries an ultimate completion date of September 10, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Dasatinib 100 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $39,326.10 and an ultimate completion date of September 9, 2025. The contract carries no set-aside designation and was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $5,293.34 delivery order to AmerisourceBergen Drug Corp for 60-count tablets of Dasatinib 70 mg, a pharmaceutical product used in cancer treatment. This competitively awarded, firm fixed-price contract has an ultimate completion date of July 1, 2025, and carries no set-aside designation. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- AmerisourceBergen Drug Corp was awarded a competitively-bid delivery order valued at $6,924.66 by the Defense Logistics Agency's Medical Supply Chain on September 17, 2025, for the supply of Dasatinib 50 mg tablets in quantities of 60. The non-set-aside contract carries a firm fixed price structure with an ultimate completion date of September 18, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Dasatinib is a tyrosine kinase inhibitor used...
- The Defense Logistics Agency awarded a $30,587.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-count bottles of Dasatinib 50 mg tablets, with an ultimate completion date of July 29, 2025. This non-set-aside contract was competitively awarded on July 28, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...